There's nothing wrong with Big Pharma stocks, but investors need to realize they're not the only game in town. We're talking about a group of pharmaceutical stocks that possess an astounding 80% of the prescription drug market.
According to Money Morning’s BioScience Investment Specialist Ernie Tremblay, this group is an extremely profitable, and simple, way to play the pharmaceutical industry.